Gellan gum is unusual among hydrocolloids in that it has a real pharmaceutical career alongside its food career. It is an approved excipient, it appears in marketed ophthalmic products, and it has an active role in drug delivery research. For suppliers, pharmaceutical grade is a different product and a different business.
Why pharma uses gellan gum
Three properties make it attractive in pharmaceutical formulation:
- Low use level with high functionality. It forms gels and suspends particles at concentrations well below 1 %, which is important when the excipient must not dominate the formulation.
- Ion-triggered gelation. The fact that low acyl gellan gum sets in the presence of cations is exploitable. A formulation can be a free-flowing liquid in the bottle and thicken only after contact with physiological fluids.
- Biocompatibility and a strong safety file. Fermentation-derived, non-animal, non-immunogenic, with an ADI "not specified".
In situ gelling: the flagship application
The best-known pharmaceutical use is in situ gelling ophthalmic systems. The formulation is delivered as a liquid drop; gellan gum in the drop is exposed to the calcium and other cations in the tear film and forms a gel on the eye surface. The result is increased precorneal residence time compared with a simple aqueous drop, without the blurring that comes from a pre-thickened gel.
A widely cited example is a timolol maleate ophthalmic gel-forming solution based on gellan gum — the technology behind the Gelrite brand name. This application is worth knowing about because it demonstrates the mechanism in its purest form: a polymer that is mobile until it meets the right ions.
Other pharmaceutical and biomedical applications include:
| Application | Mechanism |
|---|---|
| Oral suspensions | Yield stress keeps insoluble drug particles suspended |
| Controlled-release matrices | Gel layer slows drug diffusion |
| Taste masking | Gel network reduces contact with taste receptors |
| Wound dressings and hydrogels | Hydrated network maintains a moist environment |
| Tissue engineering and bioprinting | A printable, cell-compatible matrix |
What makes a material "pharmaceutical grade"
Pharmaceutical grade is not simply a finer grind of food grade. The differences are in the specification, the quality system and the paperwork.
Additional testing. Beyond the food-grade parameters, a pharmacopoeial-grade excipient is tested against monographs in the relevant pharmacopoeia, together with general chapters covering:
- Elemental impurities — USP <232> / <233> and ICH Q3D, with limits derived from permitted daily exposures
- Microbiological quality — total aerobic microbial count, total combined yeasts and moulds, and absence of specified organisms
- Bacterial endotoxins — USP <85>, where the route of administration requires it
- Residual solvents — ICH Q3C, relevant where alcohol is used in recovery
- Loss on drying, ash, viscosity — defined by the monograph
Quality system. Excipient manufacture is expected to follow GMP appropriate to excipients — the IPEC-PQG GMP guide is the usual reference — with audit rights, change control and deviation management. Certification schemes such as EXCiPACT exist to give buyers third-party assurance.
Regulatory support. Drug manufacturers typically require a Drug Master File or equivalent, a stability package, and a commitment to notify customers before any change in process, source or specification. Change control is the part that catches food suppliers out: a change that is invisible in food use can invalidate a customer's regulatory submission.
What a food-grade supplier must change
Moving from food to pharma grade is not a labelling exercise. It normally requires:
- A separate, dedicated or rigorously segregated production campaign, or a fully dedicated line
- An analytical programme covering the pharmacopoeial tests, not just the food specification
- A documented quality management system with audit readiness
- Regulatory affairs capability to support customer filings
- Retention samples and stability data spanning years, not months
That is why the number of suppliers offering genuine pharmaceutical grade is much smaller than the number offering food grade, and why the price gap is substantial.
What to ask
If you are sourcing for pharmaceutical use:
- Which pharmacopoeial monograph, and which edition, do you release against?
- Can you supply a Drug Master File or equivalent open part?
- What is your elemental impurity strategy, and how do you derive excipient limits from the oral PDE?
- What are your microbiological and endotoxin specifications?
- What is your change notification procedure, and what notice period do you commit to?
- Who has audited you, and can we audit?
For material and documentation enquiries covering food-grade and higher-specification gellan gum (E418), see Cinogel.
Part of the E418.org gellan gum knowledge base. Pharmaceutical applications are subject to national medicines regulation; this article is technical background, not regulatory advice.